Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Graft Polymer (UK) PLC ( (GB:SVNS) ) has provided an announcement.
Solvonis Therapeutics PLC has announced its total voting rights, confirming that the company’s issued share capital consists of 5,908,770,690 Ordinary Shares, each with one voting right. This information is crucial for shareholders to determine their interest in the company’s share capital, which could impact their decision-making and investment strategies.
More about Graft Polymer (UK) PLC
Solvonis Therapeutics PLC is a clinical-stage biopharmaceutical company that specializes in developing innovative medicines aimed at treating addiction and mental health disorders.
Average Trading Volume: 14,486,885
Technical Sentiment Signal: Sell
Current Market Cap: £7.68M
For detailed information about SVNS stock, go to TipRanks’ Stock Analysis page.